In this issue

More is being done to tackle ‘NTDs’ as research reveals their impact on countries’ growth

Economic reality spurs intervention

More is being done to tackle ‘NTDs’ as research reveals their impact on countries’ growth, writes Andrew Jack


Focus on neglected diseases in different parts of the world
vaccine development at the Sanofi Pasteur site in France
©Vincent Moncorgé

Prevention: Science is fighting the dengue war on four fronts

Developing a vaccine against dengue is especially difficult – but potential benefits are enormous, says Denise Roland

A little effort can produce great strides

Andrew Jack hears from John Kufuor, former president of Ghana, what 50 cents can do

Vector control: Ruining the mosquito’s sex life may pay

Work to halt life cycle is promising, says Clive Cookson

Waiting for a breakthrough: volunteers for dengue clinical trials at the Ratchaburi hospital near Bangkok, Thailand
©Sanofi Pasteur

Research: Funds sharpen scientific focus

The response to exotic parasites may underpin future cancer treatments, writes Clive Cookson

Linkage: Joint approach is still a dream

Synergy would help in tackling diseases, writes Andrew Jack

United States: Poor hit hardest by chronic infections

Tropical diseases can still be deadly in the west, explains Alan Rappeport

Eradication: Tide may be turning against guinea worm

Simple, practical steps involving communities have been vital in the fight against this debilitating parasite, says Sarah Murray

Research: A shared way forward offers hope

Global co-operation may provide many of the answers, writes Andrew Jack

Corporate efforts: Companies strive for better outcomes from donations

Big pharma is stepping up efforts to aid poorer nations, says Andrew Jack

Priority review vouchers: Glory days hover in the distance

Scheme designed to encourage research has had few takers, says Andrew Jack